Welcome to our dedicated page for Kronos Adv Tech news (Ticker: KNOS), a resource for investors and traders seeking the latest updates and insights on Kronos Adv Tech stock.
Kronos Advanced Technologies, Inc. develops and commercializes health, wellness, air-quality, dental imaging, and advanced energy technologies through product lines and subsidiaries. Company news commonly covers Kronos air purification and air disinfection products, including FDA-cleared purifier models, reusable-filter technology, and graphene face masks for indoor and outdoor air-quality applications.
Updates also focus on controlled subsidiary Zyppah, Inc., a consumer sleep and wellness business with patented, FDA-cleared snoring and sleep-related solutions sold through direct-to-consumer digital channels and online marketplaces. Other recurring themes include KronosMD’s S-WAVE radiation-free intraoral ultrasound imaging platform, Atomiq’s nuclear battery technology and patent portfolio, subsidiary ownership matters, product commercialization plans, and shareholder capital actions such as special dividends.
Kronos Advanced Technologies (OTC: KNOS) has announced the filing of a trademark for its brand to be utilized in the Metaverse. Joining industry giants like Meta and Nike, Kronos aims to establish a virtual commerce presence. Bloomberg Intelligence projects the Metaverse market could reach $800 billion by 2024, with opportunities in gaming and live events. CEO Michael Rubinov expressed optimism about securing competitive advantages through these digital assets, with further trademark filings planned for the future.
Kronos Advanced Technologies (OTC: KNOS) announced enhanced filtration efficiency for its 5-ply graphene face masks, achieving over 99.9% efficiency in bacterial and viral filtration as validated by Nelson Labs. These masks exceed the performance of ASTM Level 3 masks, the highest FDA rating. As mask usage becomes more common post-pandemic, the company anticipates sustained demand for high-quality masks in various industries. The masks are produced in the USA, positioning Kronos uniquely in the market, while public health guidelines continue to support mask-wearing in high transmission areas.
Kronos Advanced Technologies, Inc. (OTC: KNOS) announced a registration statement on Form S-1 with the SEC for a proposed $10 million stock offering. The company has entered a Common Stock Purchase Agreement with Dutchess Capital Growth Fund LP to finance renovations of its manufacturing facility and purchase advanced assembly lines. This funding will support the development of their patented air purification products and operational expenses. Recent operational highlights include securing PPE contracts and acquiring new manufacturing space.
Kronos Advanced Technologies, Inc. (OTC: KNOS), has announced a significant contract for procuring Personal Protective Equipment (PPE), medical gloves, masks, and COVID-19 test kits. This initiative supports their growth strategy, with plans to expand supply contracts in 2022. CEO Michael Rubinov highlighted the high demand for these products amid the ongoing COVID-19 crisis, especially with the new variant driving infection rates. The company is also making improvements to its West Virginia factory and preparing for a secondary public offering, alongside developing innovative consumer electronics.
Kronos Advanced Technologies (OTC: KNOS) has announced plans to launch an e-commerce Metaverse store, aiming to enhance digital shopping experiences. The company is among the first to recognize the potential of the Metaverse for retail, similar to the early days of the Internet. With a partnership with BOTS INC (OTC: BTZI), Kronos will offer unique shopping experiences allowing customers to browse and virtually test products. The global Metaverse market is expected to grow significantly, with a CAGR of 43.3% by 2028. Kronos continues to innovate in air purification, featuring patented technologies that eliminate airborne contaminants.
Konos Advanced Technologies (OTC: KNOS) has finalized the acquisition of a state-of-the-art design and manufacturing facility located on the West Virginia and Ohio border. This 85,000 square foot facility is equipped with robotic assembly equipment and will serve as the cornerstone for the company's strategic initiatives aimed at reshoring supply chains and enhancing manufacturing processes. The transition is also expected to create 300 jobs in the local area, supporting access to a workforce within reach of major U.S. metropolitan areas, thereby fostering competitive advantages in the market.
Kronos Advanced Technologies, Inc. (OTC: KNOS) announces the return of Zyppah's Black Friday savings events, fueled by positive feedback from past promotions. Zyppah offers a unique anti-snoring solution with a patented tongue guard, significantly impacting the sleep health market. The device is the #1 marketed anti-snoring product, receiving FDA clearance for OTC sale. Notably, the upcoming event will raise prices post-Black Friday, counter to typical practices. Additionally, a national public awareness campaign is set to launch, highlighting the importance of sleep health and indoor air quality.
Kronos Advanced Technologies, Inc. (OTC: KNOS) announced it will start accepting Shiba Inu (SHIB) cryptocurrency for its products, following its previous acceptance of Dogecoin. This decision aligns with the surge in popularity of SHIB, which recently hit a market value of $39 billion, surpassing Dogecoin. Kronos aims to attract the Shiba Inu community, leveraging its growth in online shopping and cryptocurrencies. Company President Michael Rubinov emphasized the importance of adapting payment options for modern consumers, as they aim to provide innovative air purification solutions.
Kronos Advanced Technologies (KNOS) has acquired the majority shares of Zyppah Inc, a top developer of anti-snoring devices, to enhance its air purification product line. This strategic acquisition positions KNOS to serve over 90 million adults affected by sleep disorders in the U.S.
Zyppah's patented mouthpiece boasts a 91% success rate in clinical studies, significantly higher than competitors. The merger aligns with Kronos's mission to improve the human condition and potentially triples KNOS's revenue in the upcoming fiscal quarter.
Kronos Advanced Technologies (KNOS) reported a remarkable financial year ending June 30, 2021, with total revenue soaring over 1200% to $504,000 and gross profit climbing 660%. The company's net tangible assets increased to $3,159,453, solidifying its position as a Penny Stock Exempt entity on OTC Markets. CEO Michael Rubinov highlighted successful strategic execution aimed at profitability and enhancing shareholder value. Kronos continues to innovate in air purification technology, emphasizing high efficiency and low maintenance costs across its product range.